BJP CPD Online e-learning site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

The British Journal of Psychiatry (2007) 190: 357-358. doi: 10.1192/bjp.bp.106.022590
© 2007 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carrasco, J. L.
Right arrow Articles by López-Ibor, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carrasco, J. L.
Right arrow Articles by López-Ibor, J. J.

SHORT REPORTS

Hypothalamic–pituitary–adrenal axis response in borderline personality disorder without post-traumatic features

Jose L. Carrasco, MD, Marina Díaz-Marsá, MD, Jose I. Pastrana, MD, Rosa Molina, MD, Loreto Brotons, MD and María I. López-Ibor, MD

Biological Psychiatry Research Programme, Complutense University, Madrid

Juan J. López-Ibor, MD

Department of Psychiatry, Hospital Clínico San Carlos, Madrid, Spain

Correspondence: Jose L. Carrasco, MD, Department of Psychiatry, Hospital Clínico San Carlos. c/Martin Lagos s/n, 28040 Madrid, Spain. Email: jcarrasco.hcsc{at}salud.madrid.org

Declaration of interest None.

Hypothalamic–pituitary–adrenal (HPA) axis sensitivity was investigated in 32 non-medicated patients with borderline personality disorder without comorbid post-traumatic syndromes and in 18 normal individuals using a modified dexamethasone suppression test (0.25 mg). Enhanced cortisol suppression was found in the patients v. controls (P<0.05) and the percentage of participant's with non-suppression was smaller in the patient (34%) than in the control group (89%) (P<0.01). Baseline cortisol levels in the patients were also lower than in the controls (P<0.05). The 0.25 mg dexamethasone suppression test reveals increased feedback inhibition of the HPA in borderline personality disorder.


Related articles in BJP:

From the Editor's desk
Peter Tyrer
BJP 2007 190: 370. [Full Text]  





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2007 The Royal College of Psychiatrists.